-
1
-
-
75149190139
-
Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT
-
November
-
Fukushima T., Takeshima H., Kataoka H. Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT. Anticancer Research 2009, 29(November (11)):4845-4854.
-
(2009)
Anticancer Research
, vol.29
, Issue.11
, pp. 4845-4854
-
-
Fukushima, T.1
Takeshima, H.2
Kataoka, H.3
-
2
-
-
70350741355
-
Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients
-
November
-
Felsberg J., Rapp M., Loeser S., Fimmers R., Stummer W., Goeppert M., et al. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients. Clin Cancer Res 2009, 15(November (21)):6683-6693.
-
(2009)
Clin Cancer Res
, vol.15
, Issue.21
, pp. 6683-6693
-
-
Felsberg, J.1
Rapp, M.2
Loeser, S.3
Fimmers, R.4
Stummer, W.5
Goeppert, M.6
-
3
-
-
69949142058
-
Dendritic cell therapy of high-grade, gliomas
-
October
-
Van Gool S., Maes W., Ardon H., Verschuere T., Van Cauter S., De Vleeschouwer S. Dendritic cell therapy of high-grade, gliomas. Brain Pathology (Zurich, Switzerland) 2009, 19(October (4)):694-712.
-
(2009)
Brain Pathology (Zurich, Switzerland)
, vol.19
, Issue.4
, pp. 694-712
-
-
Van Gool, S.1
Maes, W.2
Ardon, H.3
Verschuere, T.4
Van Cauter, S.5
De Vleeschouwer, S.6
-
4
-
-
69249192688
-
Immunobiological and experimental aspects of malignant astrocytoma
-
July
-
Nano R., Capelli E., Facoetti A., Benericetti E. Immunobiological and experimental aspects of malignant astrocytoma. Anticancer Research 2009, 29(July (7)):2461-2465.
-
(2009)
Anticancer Research
, vol.29
, Issue.7
, pp. 2461-2465
-
-
Nano, R.1
Capelli, E.2
Facoetti, A.3
Benericetti, E.4
-
6
-
-
58149302431
-
CDNA clone, prokaryotic expression and purification of human interleukin-13 receptor [alpha]2 chain
-
March
-
Yu W., Su Z., Wu Z., Mao X., Zheng W., Zeng Y. CDNA clone, prokaryotic expression and purification of human interleukin-13 receptor [alpha]2 chain. Cancer Immunology, Immunotherapy 2009, 58(March (3)):409-413.
-
(2009)
Cancer Immunology, Immunotherapy
, vol.58
, Issue.3
, pp. 409-413
-
-
Yu, W.1
Su, Z.2
Wu, Z.3
Mao, X.4
Zheng, W.5
Zeng, Y.6
-
7
-
-
70349488509
-
Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice
-
September
-
Warren M.A., Shoemaker S.F., Shealy D.J., Bshar W., Ip M.M. Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice. Molecular Cancer Therapeutics 2009, 8(September (9)):2655-2663.
-
(2009)
Molecular Cancer Therapeutics
, vol.8
, Issue.9
, pp. 2655-2663
-
-
Warren, M.A.1
Shoemaker, S.F.2
Shealy, D.J.3
Bshar, W.4
Ip, M.M.5
-
8
-
-
65849304139
-
The ectopic expression of IFN regulatory factor 4-binding protein is correlated with the malignant behavior of human breast cancer cells
-
July
-
Li P., Zhang Z., Wang Q., Li S., Zhang Y., Bian X., et al. The ectopic expression of IFN regulatory factor 4-binding protein is correlated with the malignant behavior of human breast cancer cells. International Immunopharmacology 2009, 9(July (7-8)):1002-1009.
-
(2009)
International Immunopharmacology
, vol.9
, Issue.7-8
, pp. 1002-1009
-
-
Li, P.1
Zhang, Z.2
Wang, Q.3
Li, S.4
Zhang, Y.5
Bian, X.6
-
9
-
-
67349167363
-
Ablation of T cell immunity differentially influences tumor risk in inbred BD rat strains
-
August
-
Marx J.A., Rohrborn A.J., Koelsch B.U., Fischer C., Herrmann T., Pietsch T., et al. Ablation of T cell immunity differentially influences tumor risk in inbred BD rat strains. Cancer Immunology, Immunotherapy 2009, 58(August (8)):1287-1295.
-
(2009)
Cancer Immunology, Immunotherapy
, vol.58
, Issue.8
, pp. 1287-1295
-
-
Marx, J.A.1
Rohrborn, A.J.2
Koelsch, B.U.3
Fischer, C.4
Herrmann, T.5
Pietsch, T.6
-
10
-
-
70349563144
-
Normal and pathological V(D)J recombination: contribution to the understanding of human lymphoid malignancies
-
Dadi S., Le Noir S., Asnafi V., Beldjord K., Macintyre E.A. Normal and pathological V(D)J recombination: contribution to the understanding of human lymphoid malignancies. Advances in Experimental Medicine and Biology 2009, 650:180-194.
-
(2009)
Advances in Experimental Medicine and Biology
, vol.650
, pp. 180-194
-
-
Dadi, S.1
Le Noir, S.2
Asnafi, V.3
Beldjord, K.4
Macintyre, E.A.5
-
11
-
-
70449711157
-
Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts
-
October
-
Le Dieu R., Taussig D.C., Ramsay A.G., Mitter R., Miraki-Moud F., Fatah R., et al. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. Blood 2009, 114(October (18)):3909-3916.
-
(2009)
Blood
, vol.114
, Issue.18
, pp. 3909-3916
-
-
Le Dieu, R.1
Taussig, D.C.2
Ramsay, A.G.3
Mitter, R.4
Miraki-Moud, F.5
Fatah, R.6
-
12
-
-
69249208557
-
Immunotherapy of head and neck cancer: current and future considerations
-
Rapidis A.D., Wolf G.T. Immunotherapy of head and neck cancer: current and future considerations. Journal of Oncology 2009, 2009:346345.
-
(2009)
Journal of Oncology
, vol.2009
, pp. 346345
-
-
Rapidis, A.D.1
Wolf, G.T.2
-
13
-
-
0031888608
-
Immunological ignorance of silent antigens as an explanation of tumor evasion
-
January
-
Chen L. Immunological ignorance of silent antigens as an explanation of tumor evasion. Immunology Today 1998, 19(January (1)):27-30.
-
(1998)
Immunology Today
, vol.19
, Issue.1
, pp. 27-30
-
-
Chen, L.1
-
14
-
-
0036911269
-
Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells
-
December
-
Spiotto M.T., Yu P., Rowley D.A., Nishimura M.I., Meredith S.C., Gajewski T.F., et al. Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity 2002, 17(December (6)):737-747.
-
(2002)
Immunity
, vol.17
, Issue.6
, pp. 737-747
-
-
Spiotto, M.T.1
Yu, P.2
Rowley, D.A.3
Nishimura, M.I.4
Meredith, S.C.5
Gajewski, T.F.6
-
15
-
-
0034235794
-
Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation
-
July
-
Bromley S.K., Peterson D.A., Gunn M.D., Dustin M.L. Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. Journal of Immunology 2000, 165(July (1)):15-19.
-
(2000)
Journal of Immunology
, vol.165
, Issue.1
, pp. 15-19
-
-
Bromley, S.K.1
Peterson, D.A.2
Gunn, M.D.3
Dustin, M.L.4
-
16
-
-
0035890419
-
WWOX, the FRA16D gene, behaves as a suppressor of tumor growth
-
November
-
Bednarek A.K., Keck-Waggoner C.L., Daniel R.L., Laflin K.J., Bergsagel P.L., Kiguchi K., et al. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Research 2001, 61(November (22)):8068-8073.
-
(2001)
Cancer Research
, vol.61
, Issue.22
, pp. 8068-8073
-
-
Bednarek, A.K.1
Keck-Waggoner, C.L.2
Daniel, R.L.3
Laflin, K.J.4
Bergsagel, P.L.5
Kiguchi, K.6
-
17
-
-
0034655131
-
WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer
-
April
-
Bednarek A.K., Laflin K.J., Daniel R.L., Liao Q., Hawkins K.A., Aldaz C.M. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Research 2000, 60(April (8)):2140-2145.
-
(2000)
Cancer Research
, vol.60
, Issue.8
, pp. 2140-2145
-
-
Bednarek, A.K.1
Laflin, K.J.2
Daniel, R.L.3
Liao, Q.4
Hawkins, K.A.5
Aldaz, C.M.6
-
18
-
-
85047700355
-
Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors
-
March
-
Driouch K., Prydz H., Monese R., Johansen H., Lidereau R., Frengen E. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene 2002, 21(March (12)):1832-1840.
-
(2002)
Oncogene
, vol.21
, Issue.12
, pp. 1832-1840
-
-
Driouch, K.1
Prydz, H.2
Monese, R.3
Johansen, H.4
Lidereau, R.5
Frengen, E.6
-
19
-
-
73349097291
-
Comparative mapping and genomic annotation of the bovine oncosuppressor gene WWOX
-
Manera S., Bonfiglio S., Malusa A., Denis C., Boussaha M., Russo V., et al. Comparative mapping and genomic annotation of the bovine oncosuppressor gene WWOX. Cytogenetic and Genome Research 2009, 126(1-2):186-193.
-
(2009)
Cytogenetic and Genome Research
, vol.126
, Issue.1-2
, pp. 186-193
-
-
Manera, S.1
Bonfiglio, S.2
Malusa, A.3
Denis, C.4
Boussaha, M.5
Russo, V.6
-
20
-
-
70450184078
-
Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene
-
Ludes-Meyers J.H., Kil H., Parker-Thornburg J., Kusewitt D.F., Bedford M.T., Aldaz C.M. Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene. PloS One 2009, 4(11):e7775.
-
(2009)
PloS One
, vol.4
, Issue.11
-
-
Ludes-Meyers, J.H.1
Kil, H.2
Parker-Thornburg, J.3
Kusewitt, D.F.4
Bedford, M.T.5
Aldaz, C.M.6
-
21
-
-
70350463840
-
WWOX: its genomics, partners, and functions
-
November
-
Del Mare S., Salah Z., Aqeilan R.I. WWOX: its genomics, partners, and functions. Journal of Cellular Biochemistry 2009, 108(November (4)):737-745.
-
(2009)
Journal of Cellular Biochemistry
, vol.108
, Issue.4
, pp. 737-745
-
-
Del Mare, S.1
Salah, Z.2
Aqeilan, R.I.3
-
22
-
-
44449176212
-
WWOX tumor suppressor gene
-
July
-
Yang J., Zhang W. WWOX tumor suppressor gene. Histology and Histopathology 2008, 23(July (7)):877-882.
-
(2008)
Histology and Histopathology
, vol.23
, Issue.7
, pp. 877-882
-
-
Yang, J.1
Zhang, W.2
-
23
-
-
27644582835
-
Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR
-
November
-
Thavathiru E., Ludes-Meyers J.H., MacLeod M.C., Aldaz C.M. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR. Molecular Carcinogenesis 2005, 44(November (3)):174-182.
-
(2005)
Molecular Carcinogenesis
, vol.44
, Issue.3
, pp. 174-182
-
-
Thavathiru, E.1
Ludes-Meyers, J.H.2
MacLeod, M.C.3
Aldaz, C.M.4
-
24
-
-
26844437227
-
WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome
-
Nunez M.I., Rosen D.G., Ludes-Meyers J.H., Abba M.C., Kil H., Page R., et al. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC Cancer 2005, 5:64.
-
(2005)
BMC Cancer
, vol.5
, pp. 64
-
-
Nunez, M.I.1
Rosen, D.G.2
Ludes-Meyers, J.H.3
Abba, M.C.4
Kil, H.5
Page, R.6
-
25
-
-
66349110227
-
WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3
-
June
-
Gourley C., Paige A.J., Taylor K.J., Ward C., Kuske B., Zhang J., et al. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. Cancer Research 2009, 69(June (11)):4835-4842.
-
(2009)
Cancer Research
, vol.69
, Issue.11
, pp. 4835-4842
-
-
Gourley, C.1
Paige, A.J.2
Taylor, K.J.3
Ward, C.4
Kuske, B.5
Zhang, J.6
-
26
-
-
67650996249
-
Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features
-
August
-
Bloomston M., Kneile J., Butterfield M., Dillhoff M., Muscarella P., Ellison E.C., et al. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features. Annals of Surgical Oncology 2009, 16(August (8)):2331-2338.
-
(2009)
Annals of Surgical Oncology
, vol.16
, Issue.8
, pp. 2331-2338
-
-
Bloomston, M.1
Kneile, J.2
Butterfield, M.3
Dillhoff, M.4
Muscarella, P.5
Ellison, E.C.6
-
27
-
-
84861651822
-
WWOX-mediated apoptosis in A549 cells mainly involves the mitochondrial pathway
-
July
-
Zhang P., Jia R., Ying L., Liu B., Qian G., Fan X., et al. WWOX-mediated apoptosis in A549 cells mainly involves the mitochondrial pathway. Molecular Medicine Reports 2012, 6(July (1)):121-124.
-
(2012)
Molecular Medicine Reports
, vol.6
, Issue.1
, pp. 121-124
-
-
Zhang, P.1
Jia, R.2
Ying, L.3
Liu, B.4
Qian, G.5
Fan, X.6
-
28
-
-
67650500993
-
Cisplatinum and BCNU chemotherapy in primary glioblastoma patients
-
August
-
Silvani A., Gaviani P., Lamperti E.A., Eoli M., Falcone C., Dimeco F., et al. Cisplatinum and BCNU chemotherapy in primary glioblastoma patients. Journal of Neuro-Oncology 2009, 94(August (1)):57-62.
-
(2009)
Journal of Neuro-Oncology
, vol.94
, Issue.1
, pp. 57-62
-
-
Silvani, A.1
Gaviani, P.2
Lamperti, E.A.3
Eoli, M.4
Falcone, C.5
Dimeco, F.6
-
29
-
-
64249172854
-
Localized BCNU chemotherapy and the multimodal management of malignant glioma
-
January
-
La Rocca R.V., Mehdorn H.M. Localized BCNU chemotherapy and the multimodal management of malignant glioma. Current Medical Research and Opinion 2009, 25(January (1)):149-160.
-
(2009)
Current Medical Research and Opinion
, vol.25
, Issue.1
, pp. 149-160
-
-
La Rocca, R.V.1
Mehdorn, H.M.2
-
30
-
-
39449084703
-
Radiotherapy induced glioblastoma in a child previously treated for cerebellar medulloblastoma (case report and review of the literature)
-
Pavelka Z., Brichtova E., Kren L., Skotakova J., Oltova A., Slampa P., et al. Radiotherapy induced glioblastoma in a child previously treated for cerebellar medulloblastoma (case report and review of the literature). Klinicka Onkologie 2008, 21(1):31-34.
-
(2008)
Klinicka Onkologie
, vol.21
, Issue.1
, pp. 31-34
-
-
Pavelka, Z.1
Brichtova, E.2
Kren, L.3
Skotakova, J.4
Oltova, A.5
Slampa, P.6
-
31
-
-
74349117866
-
Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion
-
December
-
Han S.J., Ahn B.J., Waldron J.S., Yang I., Fang S., Crane C.A., et al. Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion. Neuroreport 2009, 20(December (18)):1597-1602.
-
(2009)
Neuroreport
, vol.20
, Issue.18
, pp. 1597-1602
-
-
Han, S.J.1
Ahn, B.J.2
Waldron, J.S.3
Yang, I.4
Fang, S.5
Crane, C.A.6
-
32
-
-
67651171652
-
Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast and prostate carcinoma without impacting T cell function
-
July-August
-
Crane C., Panner A., Pieper R.O., Arbiser J., Parsa A.T. Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast and prostate carcinoma without impacting T cell function. Journal of Immunotherapy 2009, 32(July-August (6)):585-592.
-
(2009)
Journal of Immunotherapy
, vol.32
, Issue.6
, pp. 585-592
-
-
Crane, C.1
Panner, A.2
Pieper, R.O.3
Arbiser, J.4
Parsa, A.T.5
-
33
-
-
50849126860
-
Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: downregulation of multiple proapoptotic factors
-
June
-
Gomez G.G., Hickey M.J., Tritz R., Kruse C.A. Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: downregulation of multiple proapoptotic factors. Gene Therapy & Molecular Biology 2008, 12(June (1)):101-110.
-
(2008)
Gene Therapy & Molecular Biology
, vol.12
, Issue.1
, pp. 101-110
-
-
Gomez, G.G.1
Hickey, M.J.2
Tritz, R.3
Kruse, C.A.4
-
34
-
-
1842581808
-
The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma
-
April
-
Guler G., Uner A., Guler N., Han S.Y., Iliopoulos D., Hauck W.W., et al. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer 2004, 100(April (8)):1605-1614.
-
(2004)
Cancer
, vol.100
, Issue.8
, pp. 1605-1614
-
-
Guler, G.1
Uner, A.2
Guler, N.3
Han, S.Y.4
Iliopoulos, D.5
Hauck, W.W.6
-
35
-
-
2442707675
-
Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer
-
April
-
Watson J.E., Doggett N.A., Albertson D.G., Andaya A., Chinnaiyan A., van Dekken H., et al. Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer. Oncogene 2004, 23(April (19)):3487-3494.
-
(2004)
Oncogene
, vol.23
, Issue.19
, pp. 3487-3494
-
-
Watson, J.E.1
Doggett, N.A.2
Albertson, D.G.3
Andaya, A.4
Chinnaiyan, A.5
van Dekken, H.6
-
36
-
-
0344100087
-
WWOX, the common chromosomal fragile site, FRA16D, cancer gene
-
Ludes-Meyers J.H., Bednarek A.K., Popescu N.C., Bedford M., Aldaz C.M. WWOX, the common chromosomal fragile site, FRA16D, cancer gene. Cytogenetic and Genome Research 2003, 100(1-4):101-110.
-
(2003)
Cytogenetic and Genome Research
, vol.100
, Issue.1-4
, pp. 101-110
-
-
Ludes-Meyers, J.H.1
Bednarek, A.K.2
Popescu, N.C.3
Bedford, M.4
Aldaz, C.M.5
-
37
-
-
67749116085
-
WWOX, the tumour suppressor gene affected in multiple cancers
-
May
-
Lewandowska U., Zelazowski M., Seta K., Byczewska M., Pluciennik E., Bednarek A.K. WWOX, the tumour suppressor gene affected in multiple cancers. Journal of Physiology Pharmacology 2009, 60(May (Suppl. 1)):47-56.
-
(2009)
Journal of Physiology Pharmacology
, vol.60
, Issue.SUPPL. 1
, pp. 47-56
-
-
Lewandowska, U.1
Zelazowski, M.2
Seta, K.3
Byczewska, M.4
Pluciennik, E.5
Bednarek, A.K.6
-
38
-
-
34347371806
-
WWOX in biological control and tumorigenesis
-
August
-
Aqeilan R.I., Croce C.M. WWOX in biological control and tumorigenesis. Journal of Cellular Physiology 2007, 212(August (2)):307-310.
-
(2007)
Journal of Cellular Physiology
, vol.212
, Issue.2
, pp. 307-310
-
-
Aqeilan, R.I.1
Croce, C.M.2
|